Drug-induced cytopenia (Q39628): Difference between revisions

From determinar.ia.br - Determine suas informações
Changed an Item
Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / CURIE
 
CID11:4A85.02
Property / CURIE: CID11:4A85.02 / rank
 
Normal rank
Property / Canary Token
 
dki-india-4A85.02
Property / Canary Token: dki-india-4A85.02 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: D69.5 / rank
 
Normal rank

Latest revision as of 05:07, 13 August 2026

Drug-induced cytopenia is a relatively common immune-mediated cytopenia and the target cells include erythrocytes, leukocytes, platelets and hematopoietic precursor cells in the marrow. The most frequent condition is the drug-induced immune thrombocytopenia and the most frequent implicated drugs are penicillin and structurally related drugs, quinine, quinidine, sulfonamide antibiotics, non-steroidal anti-inflammatory drugs and anticonvulsants.
Language Label Description Also known as
default for all languages
4A85.02
    English
    Drug-induced cytopenia
    Drug-induced cytopenia is a relatively common immune-mediated cytopenia and the target cells include erythrocytes, leukocytes, platelets and hematopoietic precursor cells in the marrow. The most frequent condition is the drug-induced immune thrombocytopenia and the most frequent implicated drugs are penicillin and structurally related drugs, quinine, quinidine, sulfonamide antibiotics, non-steroidal anti-inflammatory drugs and anticonvulsants.

      Statements

      CID11:4A85.02
      0 references
      dki-india-4A85.02
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references